Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial (Q40780423)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial |
scientific article |
Statements
1 reference
Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial (English)
1 reference
Maria Buti
1 reference
Geoff McCaughan
1 reference
Mario Rizzetto
1 reference
Michael Manns
1 reference
Didier Samuel
1 reference
Edward J Gane
1 reference
David Mutimer
1 reference
MartÃn Prieto
1 reference
José Luis Calleja
1 reference
Beat Müllhaupt
1 reference
Kosh Agarwal
1 reference
Peter Angus
1 reference
Eric M Yoshida
1 reference
Massimo Colombo
1 reference
Hadas Dvory-Sobol
1 reference
Jill Denning
1 reference
Sarah Arterburn
1 reference
Phillip S Pang
1 reference
Diana Brainard
1 reference
John G McHutchison
1 reference
Jean-François Dufour
1 reference
Hans Van Vlierberghe
1 reference
Bart van Hoek
1 reference
Xavier Forns
1 reference
SOLAR-2 investigators
1 reference
18 February 2016
1 reference
1 reference
Identifiers
1 reference